Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors

被引：0
|
作者：
Karima Saboundji
Jean-Bernard Auliac
Maurice Pérol
Géraldine François
Henri Janicot
Marie Marcq
Catherine Dubos-Arvis
Aldo Renault
Florian Guisier
Luc Odier
Radj Gervais
Christos Chouaïd
机构：
[1] CH François-Quesnay,Pneumologie et Oncologie Thoracique
[2] Centre Léon-Bérard,Oncologie
[3] CHU d’Amiens,Pneumologie et Oncologie Thoracique
[4] CHU Clermont-Ferrand,Pneumologie
[5] CHU Vendée,Pneumologie
[6] Centre François-Baclesse,Oncologie
[7] CH François-Mitterrand,Pneumologie
[8] CHU Charles-Nicolle,Pneumologie
[9] Hôpital Nord-Ouest,Pneumologie
[10] CH Intercommunal de Créteil,Pneumologie
来源：
Targeted Oncology | 2018年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 507
页数：6
相关论文
共 50 条
  • [21] Impact of EGFR-Tyrosine Kinase Inhibitors for Postoperative Recurrent Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Igawa, S.
    Sato, Y.
    Kusuhara, S.
    Harada, S.
    Shirasawa, M.
    Kurahayashi, S.
    Okuma, Y.
    Sugimoto, A.
    Sugita, K.
    Nakahara, Y.
    Otani, S.
    Fukui, T.
    Yokoba, M.
    Mitsufuji, H.
    Kubota, M.
    Katagiri, M.
    Sasaki, J.
    Masuda, N.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2126 - S2127
  • [22] Challenges in the Management of EGFR-Mutated Non-Small Cell Lung Cancer Patients with Acquired Resistance to Tyrosine Kinase Inhibitors
    Kuiper, Justine L.
    Smit, Egbert F.
    ONCOLOGY, 2014, 87 (02) : 83 - 94
  • [23] Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer
    Aredo, Jacqueline V.
    Wakelee, Heather A.
    Hui, Angela Bik-Yu
    Padda, Sukhmani K.
    Joshi, Nitin D.
    Guo, H. Henry
    Chaudhuri, Aadel
    Diehn, Maximilian
    Loo, Billy W.
    Neal, Joel W.
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 33
  • [24] Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
    Wu, Yi-Long
    Tsuboi, Masahiro
    He, Jie
    John, Thomas
    Grohe, Christian
    Majem, Margarita
    Goldman, Jonathan W.
    Laktionov, Konstantin
    Kim, Sang-We
    Kato, Terufumi
    Vu, Huu-Vinh
    Lu, Shun
    Lee, Kye-Young
    Akewanlop, Charuwan
    Yu, Chong-Jen
    de Marinis, Filippo
    Bonanno, Laura
    Domine, Manuel
    Shepherd, Frances A.
    Zeng, Lingmin
    Hodge, Rachel
    Atasoy, Ajlan
    Rukazenkov, Yuri
    Herbst, Roy S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1711 - 1723
  • [25] Adjuvant Osimertinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    Planchard, David
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1780 - 1782
  • [26] EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease
    Alzate, Juan Diego
    Mullen, Reed
    Mashiach, Elad
    Bernstein, Kenneth
    Vasconcellos, Fernando De Nigris
    Rotmann, Lauren
    Berger, Assaf
    Qu, Tanxia
    Silverman, Joshua S.
    Golfinos, John G.
    Donahue, Bernadine R.
    Kondziolka, Douglas
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (02) : 387 - 396
  • [27] MERTK Activation Drives Osimertinib Resistance in EGFR-Mutated Non-Small Cell Lung Cancer
    Yan, D.
    Huelse, J.
    Parker, R.
    Wang, X.
    Frye, S.
    Earp, H. S.
    Deryckere, D.
    Graham, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1147 - S1147
  • [28] Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary?
    Leonetti, Alessandro
    Facchinetti, Francesco
    Tiseo, Marcello
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [29] EGFR-mutated non-small lung cancer brain metastases and radiosurgery outcomes with a focus on leptomeningeal disease
    Juan Diego Alzate
    Reed Mullen
    Elad Mashiach
    Kenneth Bernstein
    Fernando De Nigris Vasconcellos
    Lauren Rotmann
    Assaf Berger
    Tanxia Qu
    Joshua S. Silverman
    John G. Golfinos
    Bernadine R. Donahue
    Douglas Kondziolka
    Journal of Neuro-Oncology, 2023, 164 (2) : 387 - 396
  • [30] Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
    Fu, Kai
    Xie, Fachao
    Wang, Fang
    Fu, Liwu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
12345